TrialReader


Registry of Secondary Revascularization

NCT03349385 — Active not recruiting, 869 participants, Hospital San Carlos, Madrid

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Multicenter Registry of Secondary Revascularization

RegistryNCT03349385, acronym REVASEC
StatusActive not recruiting
Study typeObservational
Enrollment869 (Actual)
SponsorHospital San Carlos, Madrid (Other); collaborators: Laboratorios Farmacéuticos Rovi, S.A., S&H MEDICAL SCIENCE SERVICE, S.L.
ConditionsCoronary Artery Disease Progression, Coronary Artery Disease of Significant Bypass Graft, Stent Stenosis, Stent Restenosis, Coronary Arteriosclerosis
Datesstart 2017-11-22, primary completion 2021-05-31, completion 2025-12-15 (estimated), first posted 2017-11-21, last updated 2025-04-24
Locations1 site in Spain

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Coronary Artery Disease Progression All trials for Coronary Artery Disease of Significant Bypass Graft

-Summary

The study will evaluate patients with, at least, one previous procedure of coronary revascularization (surgical, percutaneous or both), that are referred for a new, clinically indicated, diagnostic coronary angiography, to describe their clinical characteristics, management, and prognosis, and will propose a prognosis-oriented classification.

Expand all sections  ·  Collapse all

+Detailed description

Secondary or repeated revascularization refers to any repeated coronary intervention following an index coronary revascularization procedure, and represents a wide proportion of patients received in catheterization laboratories. These patients have an increased complexity and worse outcomes than patients without previous revascularization. Clinical investigation has focused in lesion-specific treatments when a single previous revascularization fails, but there is paucity of patient-level information including complex patients with multiple revascularizations. Other gaps in evidence addressed by this study are the absence of a a prognosis-oriented classification of previously revascularized patients and a clinical meaningful definition of revascularization failure. The registry as well intends to provide insights on how secondary revascularization decisions are taken and long term prognosis after secondary revascularization.

The registry of secondary revascularization (in Spanish: Registro multicéntrico de reVAscularización SECundaria, REVASEC) is a multicenter, prospective, observational cohort study that incudes consecutive patients with at least one previous coronary revascularization undergoing a clinically indicated diagnostic coronary angiography, in different Spanish hospitals. The aims are describing the incidence, clinical profile, therapeutic management and prognosis of these patients.

+Outcome measures

Primary outcomes

  • Patient-oriented composite endpoint [1 year]: Composite endpoint including: all-cause death, any myocardial infarction or any new unplanned revascularization

Secondary outcomes

  • Rates of individual components of primary outcome [1 to 5 years]: Rates of individual components of primary outcomes: all-cause death, myocardial infarction or new unplanned revascularization
  • Composite endpoint at 2 to 5 years [2 to 5 years]: Composite endpoint including: all-cause death, any myocardial infarction or new unplanned revascularization
  • Rate of failure of previous revascularization [baseline (assessed at index catheterization)]: Rate of failure of previous revascularization using the classical definition: >50% stent restenosis or >50% stenosis in a surgical graft
  • Recurrent angina (CCS class, patients reported) [1 to 5 years]: Describe the presence of recurrent angina (CCS class) and analyze its predictors
  • Feasibility of secondary revascularization [per protocol, 1 month after index catheterization]: Define the rates of successful and complete revascularization

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* Age ≥ 18 years
* Previous successful coronary revascularization, either percutaneous or surgical, in at least one vessel with diameter ≥2 mm
* Previous successful coronary revascularization must have been successful in at least one vessel and the patient must have been discharged after the previous revascularization
* Clinically indicated diagnostic coronary angiography
* Provide written informed consent

Exclusion Criteria:

* Inability or refusal to provide written informed consent
* Patient included in any other clinical trial in which the revascularization device is blind to patient or investigator, or is not commercially available
* Insufficient data about previous revascularizations
* Previous revascularization only on vessels of less than 2 mm or which was not successful in any vessel
* Previous percutaneous revascularization with simple plain old balloon angioplasty
* Index coronary angiography indicated as scheduled repeated angiography, planned percutaneous coronary intervention, or pre-surgical angiography

+Locations (1)

FacilityCityCountryStatus
Hospital Clinico San CarlosMadrid, MadridSpain

+Publications

  • Salinas P, Vilchez-Tschischke JP, Noriega F, Macaya F, Rosillo S, Garcia-Camarero T, de la Torre-Hernandez JM, de Tapia B, Jimenez-Kockar M, Regueiro A, Flores-Umanzor E, Garcia-Blas S, Gonzalez-D'Gregorio J, Gomez-Menchero AE, Diaz-Fernandez JF, Rondan J, Amat-Santos I, Ojeda S, Diez-Gil JL, de Miguel Castro A, Lozano Ruiz-Poveda F, Fernandez-Diaz JA, Manzano MC, Cruz-Gonzalez I, Pascual Tejerina V, Garcia Perez-Velasco J, Serra A, Poveda-Andres JL, Macaya C, Escaned J. Design and Rationale for a Real-World Prospective, Multicenter Registry of Myocardial Revascularization Failure and Secondary Revascularization: The REVASEC Study. Cardiovasc Revasc Med. 2022 Jul;40:50-56. doi: 10.1016/j.carrev.2021.11.015. Epub 2021 Nov 16. PMID 34857473
  • Results publication: Salinas P, Garcia-Camarero T, Jimenez-Kockar M, Regueiro A, Garcia-Blas S, Gomez-Menchero AE, Ojeda S, Vilchez-Tschischke JP, Amat-Santos I, Diez-Gil JL, Rondan J, Lozano Ruiz-Poveda F, de Miguel Castro A, Manzano MC, Pascual-Tejerina V, Cruz-Gonzalez I, Garcia Perez-Velasco J, Fernandez-Diaz JA, Escaned J; REVASEC working group (collaborators). Myocardial revascularization failure among patients requiring cardiac catheterization and secondary revascularization in contemporary clinical practice: Results of the REVASEC multicenter registry. Catheter Cardiovasc Interv. 2023 Oct;102(4):608-619. doi: 10.1002/ccd.30804. Epub 2023 Aug 15. PMID 37582340

+Investigators

My Notes